(3,9-Diazaspiro[5.5]undecan-3-yl)(3-(thiophen-2-ylmethoxy)-phenyl)methanone

ID: ALA5202160

PubChem CID: 168292453

Max Phase: Preclinical

Molecular Formula: C21H26N2O2S

Molecular Weight: 370.52

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(c1cccc(OCc2cccs2)c1)N1CCC2(CCNCC2)CC1

Standard InChI:  InChI=1S/C21H26N2O2S/c24-20(23-12-8-21(9-13-23)6-10-22-11-7-21)17-3-1-4-18(15-17)25-16-19-5-2-14-26-19/h1-5,14-15,22H,6-13,16H2

Standard InChI Key:  ILRNWAYGXRJVHI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    2.8334  -24.1603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5485  -24.5718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2606  -24.1642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2638  -23.3393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.5488  -22.9236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8305  -23.3370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4076  -24.1603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4076  -24.9875    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1221  -25.3949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8367  -24.9875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1221  -23.7403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9777  -22.9254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9798  -22.0982    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.6879  -23.3371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6863  -24.1613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3981  -24.5730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1120  -24.1618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1097  -23.3343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3973  -22.9263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8213  -22.9206    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5353  -23.3299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2469  -22.9161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9978  -23.2441    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5467  -22.6307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1328  -21.9191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3283  -22.0928    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  1  0
  7 11  1  0
  8  9  1  0
  9 10  1  0
 10  1  1  0
  1 11  1  0
  4 12  1  0
 12 13  2  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 12 14  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 22  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5202160

    ---

Associated Targets(non-human)

Gabrp GABA-A receptor; anion channel (5731 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 370.52Molecular Weight (Monoisotopic): 370.1715AlogP: 3.93#Rotatable Bonds: 4
Polar Surface Area: 41.57Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 10.33CX LogP: 3.05CX LogD: 0.29
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.89Np Likeness Score: -1.54

References

1. Bavo F, de-Jong H, Petersen J, Falk-Petersen CB, Löffler R, Sparrow E, Rostrup F, Eliasen JN, Wilhelmsen KS, Barslund K, Bundgaard C, Nielsen B, Kristiansen U, Wellendorph P, Bogdanov Y, Frølund B..  (2021)  Structure-Activity Studies of 3,9-Diazaspiro[5.5]undecane-Based γ-Aminobutyric Acid Type A Receptor Antagonists with Immunomodulatory Effect.,  64  (24.0): [PMID:34908407] [10.1021/acs.jmedchem.1c00290]

Source